# A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis

> **NCT02799030** · PHASE2 · COMPLETED · sponsor: **Biofrontera Bioscience GmbH** · enrollment: 105 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** BF-200 ALA 1%
- **DRUG:** BF-200 ALA 3%
- **DRUG:** BF-200 ALA 10%

## Key facts

- **NCT ID:** NCT02799030
- **Lead sponsor:** Biofrontera Bioscience GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2016-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02799030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02799030, "A Clinical Trial of Topical Photodynamic Therapy With 5-aminolevulinic Acid for the Treatment of Actinic Keratosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02799030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*